Sigma Healthcare Ltd traded at 3.13 this Friday February 6th, decreasing 0.03 or 0.95 percent since the previous trading session. Looking back, over the last four weeks, Sigma Healthcare lost 9.44 percent. Over the last 12 months, its price rose by 7.19 percent. Looking ahead, we forecast Sigma Healthcare Ltd to be priced at 3.03 by the end of this quarter and at 2.85 in one year, according to Trading Economics global macro models projections and analysts expectations.
Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.